These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 29580639)

  • 41. Implementation of the community network of reference laboratories for human influenza in Europe.
    Meijer A; Valette M; Manuguerra JC; Pérez-Breña P; Paget J; Brown C; van der Velden K;
    J Clin Virol; 2005 Oct; 34(2):87-96. PubMed ID: 16157259
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influenza in Poland in 2011-2012 and in 2011/2012 and 2012/2013 epidemic seasons.
    Czarkowski MP; Hallmann-Szelińska E; Staszewska E; Bednarska K; Kondratiuk K; Brydak LB
    Przegl Epidemiol; 2014; 68(3):455-63, 559-65. PubMed ID: 25391010
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Adverse drug reactions following immunization in Germany pursuant to the German Infection Protection Act and the German Medicinal Products Act from January 1, 2004 to December 31, 2005].
    Weisser K; Meyer C; Petzold D; Mentzer D; Keller-Stanislawski B
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007 Nov; 50(11):1404-17. PubMed ID: 17999134
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Testing for viral contaminants of veterinary vaccines in Hungary.
    Kulcsar G; Farsang A; Soos T
    Biologicals; 2010 May; 38(3):346-9. PubMed ID: 20338783
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combined, concurrent, and sequential administration of seasonal influenza and MF59-adjuvanted A/H5N1 vaccines: a phase II randomized, controlled trial of immunogenicity and safety in healthy adults.
    Lopez P; Caicedo Y; Sierra A; Tilman S; Banzhoff A; Clemens R
    J Infect Dis; 2011 Jun; 203(12):1719-28. PubMed ID: 21606530
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Three Rs potential in the development and quality control of immunobiologicals.
    Halder M
    ALTEX; 2001; 18 Suppl 1():13-47. PubMed ID: 11854853
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
    Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
    Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effectiveness and safety of influenza vaccination in children: European perspective.
    Heikkinen T; Heinonen S
    Vaccine; 2011 Oct; 29(43):7529-34. PubMed ID: 21820481
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Calibration of the human immunoglobulin BRPs for ACA and molecular size (batch 1) and for Fc function and molecular size (batches 1 & 2).
    Sandberg E; Costanzo A; Daas A; Buchheit KH
    Pharmeur Bio Sci Notes; 2012 Apr; 2012():1-15. PubMed ID: 23327889
    [TBL] [Abstract][Full Text] [Related]  

  • 50. United States of America Department of Health and Human Services support for advancing influenza vaccine manufacturing in the developing world.
    Perdue ML; Bright RA
    Vaccine; 2011 Jul; 29 Suppl 1():A48-50. PubMed ID: 21684430
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.
    Menzies R; Turnour C; Chiu C; McIntyre P
    Commun Dis Intell Q Rep; 2008 Jun; 32 Suppl():S2-67. PubMed ID: 18711998
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Seasonal influenza vaccines.
    Fiore AE; Bridges CB; Cox NJ
    Curr Top Microbiol Immunol; 2009; 333():43-82. PubMed ID: 19768400
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Background paper to the recommendation for the preferential use of live-attenuated influenza vaccine in children aged 2-6 years in Germany.
    Falkenhorst G; Harder T; Remschmidt C; Terhardt M; Zepp F; Ledig T; Wicker S; Keller-Stanislawski B; Mertens T
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1557-64. PubMed ID: 24170085
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phase III, randomized controlled trial to evaluate lot consistency of a trivalent subunit egg-based influenza vaccine in adults.
    Rivera L; Mazara S; Vargas M; Fragapane E; Casula D; Groth N
    Vaccine; 2012 Jul; 30(35):5285-92. PubMed ID: 22659448
    [TBL] [Abstract][Full Text] [Related]  

  • 55. EDQM biological reference preparation for rabies vaccine (inactivated) for veterinary use.
    Daas A; Bruckner L; Milne C
    Pharmeur Bio Sci Notes; 2015; 2015():57-72. PubMed ID: 26830159
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prioritization strategies for pandemic influenza vaccine in 27 countries of the European Union and the Global Health Security Action Group: a review.
    Straetemans M; Buchholz U; Reiter S; Haas W; Krause G
    BMC Public Health; 2007 Sep; 7():236. PubMed ID: 17825095
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [International trends in influenza control: preparing for the next pandemic and vaccination].
    Hirota Y
    Nihon Koshu Eisei Zasshi; 1996 Nov; 43(11):946-53. PubMed ID: 9033209
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
    Valenciano M; Kissling E; Reuss A; Rizzo C; Gherasim A; Horváth JK; Domegan L; Pitigoi D; Machado A; Paradowska-Stankiewicz IA; Bella A; Larrauri A; Ferenczi A; ; Lazar M; Pechirra P; Korczyńska MR; Pozo F; Moren A;
    Euro Surveill; 2016; 21(7):pii=30139. PubMed ID: 26924024
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reducing the use of the target animal batch safety test for veterinary vaccines.
    Roberts B; Lucken RN
    Dev Biol Stand; 1996; 86():97-102. PubMed ID: 8785997
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drivers and barriers in the consistency approach for vaccine batch release testing: Report of an international workshop.
    Bruysters MWP; Schiffelers MJ; Hoonakker M; Jungbaeck C; Ragan I; Rommel E; van der Stappen T; Viviani L; Hessel EV; Akkermans AM; Vandebriel RJ
    Biologicals; 2017 Jul; 48():1-5. PubMed ID: 28666717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.